For millions of Americans, bathroom trips bring anxiety rather than relief. Irritable bowel syndrome with constipation (IBS-C) impacts approximately one-third of all IBS cases, causing physical ...

Findings showed 30% of patients taking linaclotide 145mcg achieved the primary endpoint of combined responder. The Food and Drug Administration (FDA) has approved Linzess ® (linaclotide) for the ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

Approximately 2% of patients with irritable bowel syndrome (IBS) have a mutation of the SCN5A gene that disrupts sodium channel function, according to a genotype analysis published online March 10 in ...

A study recently published in Gastroenterology presents a possible breakthrough in the treatment of irritable bowel syndrome. According to a June 5 news release, the trial included 238 patients across ...

Irritable bowel syndrome (IBS) sufferers who followed a low-sugar, low-starch diet for one month improved their gut symptoms and lost weight, according to a study, suggesting it could be as effective ...

IBSRELA®(tenapanor) is the First and Only NHE3 Inhibitor FDA Approved for the Treatment of IBS-C in Adults First Novel Mechanism Therapy to Treat IBS-C in a Decade Product Now Available The approval ...

Ardelyx, Inc. announced that it will present data on its innovative IBSRELA® (tenapanor) at the Digestive Disease Week Conference in San Diego from May 3-6, 2025. IBSRELA is FDA-approved for treating ...

If you have irritable bowel syndrome with constipation (IBS-C), kiwifruit may ease constipation and abdominal discomfort. Kiwifruit’s soluble and insoluble fiber, low fermentable oligosaccharides, ...

Irritable bowel syndrome (IBS) is a chronic condition that can cause a number of unpleasant digestive symptoms, most notably constipation or diarrhea with abdominal pain. "Gas, cramping and food ...

Exocrine pancreatic insufficiency (EPI) and irritable bowel syndrome (IBS) are gastrointestinal (GI) conditions that share certain symptoms, such as abdominal pain, bloating, and changes to bowel ...